» Articles » PMID: 7914220

Extracellular Glutamate During Focal Cerebral Ischaemia in Rats: Time Course and Calcium Dependency

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 1994 Sep 1
PMID 7914220
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

The time course of changes in extracellular glutamic acid levels and their Ca2+ dependency were studied in the rat striatum during focal cerebral ischaemia, using microdialysis. Ischaemia-induced changes were compared with those produced by high K(+)-evoked local depolarization. To optimize time resolution, glutamate was analysed continuously as the dialysate emerged from the microdialysis probe by either enzyme fluorimetry or biosensor. The Ca2+ dependency of glutamate changes was examined by perfusing the probe with Ca(2+)-free medium. With normal artificial CSF, ischaemia produced a biphasic increase in extracellular glutamate, which started from the onset of ischaemia. During the first phase lasting approximately 10 min, dialysate glutamate level increased from 5.8 +/- 0.9 microM.min-1 to 35.8 +/- 6.2 microM where it stabilized for approximately 3 min. During the second phase dialysate glutamate increased progressively to its maximum (82 +/- 8 microM), reached after 55 min of ischaemia, where it remained for as long as it was recorded (3 h). The overall changes in extracellular glutamate were similar when Ca2+ was omitted from the perfusion medium, except that the first phase was no longer detectable and, early in ischaemia, extracellular glutamate increased at a significantly slower rate than in the control group (2.2 +/- 1 microM.min-1; p < 0.05). On the basis of these data, we propose that most of the glutamate released in the extracellular space in severe ischaemia is of metabolic origin, probably originating from both neurons and glia, and caused by altered glutamate uptake mechanisms.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Group III metabotropic glutamate receptors: guardians against excitotoxicity in ischemic brain injury, with implications for neonatal contexts.

Mielecki D, Salinska E Pharmacol Rep. 2024; 76(6):1199-1218.

PMID: 39298028 PMC: 11582219. DOI: 10.1007/s43440-024-00651-z.


Cytotoxic Edema and Adverse Clinical Outcomes in Patients with Intracerebral Hemorrhage.

Li N, Guo J, Kang K, Zhang J, Zhang Z, Liu L Neurocrit Care. 2022; 38(2):414-421.

PMID: 36180765 PMC: 10090026. DOI: 10.1007/s12028-022-01603-2.


Defining Delayed Perihematomal Edema Expansion in Intracerebral Hemorrhage: Segmentation, Time Course, Risk Factors and Clinical Outcome.

Chen Y, Qin C, Chang J, Liu Y, Zhang Q, Ye Z Front Immunol. 2022; 13:911207.

PMID: 35615357 PMC: 9125313. DOI: 10.3389/fimmu.2022.911207.


Perihematomal Edema After Intracerebral Hemorrhage: An Update on Pathogenesis, Risk Factors, and Therapeutic Advances.

Chen Y, Chen S, Chang J, Wei J, Feng M, Wang R Front Immunol. 2021; 12:740632.

PMID: 34737745 PMC: 8560684. DOI: 10.3389/fimmu.2021.740632.


Metabolic constraints of swelling-activated glutamate release in astrocytes and their implication for ischemic tissue damage.

Wilson C, Bach M, Ashkavand Z, Norman K, Martino N, Adam A J Neurochem. 2019; 151(2):255-272.

PMID: 31032919 PMC: 6817373. DOI: 10.1111/jnc.14711.